Broken String Biosciences Closes $15M Series A Funding Round
Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, has closed a US$15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures […]
